IPOs/recent issues: Virologic –

South San Francisco, Calif.

Went public 5/2/2000 at $7 a piece

Filing Range: 5 mil. shares @ $7 to $8

Shares Outstanding: 19.68 mil. shares

Underwriters: CIBC World Markets

ING Barings/Prudential Vector Healthcare

Company Counsel: Cooley Godward LLP

Manager Counsel: McDermott Will & Emery

Auditor: Ernst & Young LLP

The Company:

The company has developed a method of directly measuring the impact of genetic mutations on drug resistance and uses this information to guide therapy.

Venture Backers:

Biotech Growth S.A.

Zesiger Capital Group

Capital Management Services Inc.

Invemed Associates Inc.

Financing Rounds

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 09/01/1998 1 Expansion $100.0


(Data in $ millions)



Total Revenues: $1.1

Net Loss: -17.1